Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-417-8 | CAS number: 106-63-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
In-vitro studies: Bacterial systems
Isobutyl acrylate was tested in theassay with Salmonella typhimurium TA98, TA100, TA1535, and TA1537 in concentrations from 100 up to 10000 µg/plate with and without metabolic activation. No mutagenic effects were observed. At 3333 and 10000 µg/plate slight cytotoxicity was observed (NTP 1982, Zeiger 1987).
In-vitro studies: Mammalian cell gene mutation test
There are no mammalian cell gene mutation assays available for isobutyl acrylate. But the structurally-related acrylate esters ethyl acrylate and methyl acrylate were sufficiently tested in both the HGPRT assay and the Mouse Lymphoma TK assay.
The HGPRT assays were all negative without metabolic activation (Moore et al. 1989, 1991). In contrast, both acrylate esters were positive in the Mouse Lymphoma TK+/- mutation assay using L5178Y cells with and without metabolic activation at clearly cytotoxic concentrations (Rohm & Haas 1980, Moore 1988, 1989). The majority of the mutant colonies were small colonies, suggesting that ethyl and methyl acrylate did act via a clastogenic mechanism (Moore 1988, 1989, Amtower 1986).
More recent studies have indicated that there is an association between chromosomal aberrations and cytotoxicity at exposure concentrations which reduce cell growth to less than 50% of the control value (Galloway, 2000 and references cited therein). These data suggest that the increase in mutagenicity reported in the TK assays with ethyl and methyl acrylate may be an artifact of the experimental method.
In-vitro studies: Genotoxicity tests
There are no in vitro micronucleus assays or chromosome aberration tests available for isobutyl acrylate. In accordance with column 2 of REACH Annex VIII, no study has to be conducted since adequate data from an in vivo cytogenicity test are available.
In vivo studies
In a micronucleus test performed with isobutyl acrylate in accordance with OECD guideline 474 under GLP conditions, mice were dosed intraperitoneally with up to 1000 mg/kg bw (males) and 1250 mg/kg bw (females), isobutyl acrylate did not induce micronuclei in bone marrow at any dose level or any harvesting time used in this study (24 and 48 hours after the end of exposure). Isobutyl acrylate was considered non-clastogenic and non-aneugenic in this assay. The mean number of normochromatic erythrocytes was not increased after treatment with the test substance as compared to the controls, indicating that isobutyl acrylate had no cytotoxic effect on the bone marrow, but there were clear clinical signs of toxicity at the highest dose-levels tested (reduced activity, eyelid closure, apathy, prostrate position). The positive control substance, cyclophosphamide, induced a distinct increase of micronuclei (BASF AG 2001).
Conclusion
Isobutyl acrylate was not mutagenic in the Ames test and not clastogenic in vivo in the mouse micronucleus test.
Galloway SM (2000). Environmental and Molecular Mutagenesis 35:191-201
Short description of key information:
Isobutyl acrylate was not mutagenic in the Ames test and not clastogenic in vivo in the mouse micronucleus test.
Endpoint Conclusion:
Justification for classification or non-classification
EU classification according to Annex VI of Directive 67/548/EEC: no classification required
GHS classification (GHS UN rev.3, 2009): no classification required
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

Route: .live1